VanEck Healthcare TruSector ETF TRUH
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.10%
- Net assets
- $833K
- Holdings
- 60
- 12-month distribution yield
- 0.69%
- Asset class
- Equity
VanEck Healthcare TruSector ETF (TRUH) is an exchange-traded fund listed on the Nasdaq in the United States, issued by VanEck. Its category is Equity · US (equity). Its last price was US$31.31 on 20 Oct 2026. Its expense ratio is 0.1% a year, from its prospectus dated 20 Feb 2026. It reported net assets of US$833,118 as of 30 Jun 2026. Its latest holdings report lists 60 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$0.22 a unit, a 12-month distribution yield of 0.69%, paid quarterly.
Fees
- Total annual operating expenses (gross)
- 0.10%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.10%
- Prospectus date
- 20 Feb 2026
- Filed with the SEC
- 20 Feb 2026
Size and reporting
- Net assets
- $833,118
- Total assets
- $833,176
- Holdings as of
- 30 Jun 2026
- Report made public
- 26 Aug 2026 (57 days after the month end)
Top holdings
Largest 25 of 60 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | US5324571083 | 16.56% | $138K | Equity (common) | United States | USD |
| 2 | Johnson & Johnson | US4781601046 | 10.67% | $89K | Equity (common) | United States | USD |
| 3 | AbbVie Inc | US00287Y1091 | 7.76% | $65K | Equity (common) | United States | USD |
| 4 | UnitedHealth Group Inc | US91324P1021 | 6.59% | $55K | Equity (common) | United States | USD |
| 5 | Merck & Co Inc | US58933Y1055 | 5.54% | $46K | Equity (common) | United States | USD |
| 6 | Amgen Inc | US0311621009 | 3.39% | $28K | Equity (common) | United States | USD |
| 7 | Thermo Fisher Scientific Inc | US8835561023 | 3.25% | $27K | Equity (common) | United States | USD |
| 8 | Abbott Laboratories | US0028241000 | 2.76% | $23K | Equity (common) | United States | USD |
| 9 | Gilead Sciences Inc | US3755581036 | 2.74% | $23K | Equity (common) | United States | USD |
| 10 | Intuitive Surgical Inc | US46120E6023 | 2.48% | $21K | Equity (common) | United States | USD |
| 11 | Pfizer Inc | US7170811035 | 2.40% | $20K | Equity (common) | United States | USD |
| 12 | CVS Health Corp | US1266501006 | 2.31% | $19K | Equity (common) | United States | USD |
| 13 | Vertex Pharmaceuticals Inc | US92532F1003 | 2.21% | $18K | Equity (common) | United States | USD |
| 14 | Danaher Corp | US2358511028 | 2.10% | $18K | Equity (common) | United States | USD |
| 15 | Bristol-Myers Squibb Co | US1101221083 | 2.05% | $17K | Equity (common) | United States | USD |
| 16 | Stryker Corp | US8636671013 | 1.89% | $16K | Equity (common) | United States | USD |
| 17 | Medtronic PLC | IE00BTN1Y115 | 1.76% | $15K | Equity (common) | Ireland | USD |
| 18 | McKesson Corp | US58155Q1031 | 1.54% | $13K | Equity (common) | United States | USD |
| 19 | Elevance Health Inc | US0367521038 | 1.49% | $12K | Equity (common) | United States | USD |
| 20 | Cigna Group/The | US1255231003 | 1.26% | $10K | Equity (common) | United States | USD |
| 21 | Regeneron Pharmaceuticals Inc | US75886F1075 | 1.12% | $9K | Equity (common) | United States | USD |
| 22 | Boston Scientific Corp | US1011371077 | 1.11% | $9K | Equity (common) | United States | USD |
| 23 | HCA Healthcare Inc | US40412C1018 | 1.08% | $9K | Equity (common) | United States | USD |
| 24 | Cardinal Health Inc | US14149Y1082 | 0.97% | $8K | Equity (common) | United States | USD |
| 25 | Cencora Inc | US03073E1055 | 0.95% | $8K | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.91% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 97.80% | |
| Ireland | 2.11% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 99.91% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 87.71% | |
| Industrials | 7.31% | |
| Consumer Staples | 2.31% | |
| Technology | 0.47% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.2150
- 12-month yield
- 0.69%
- Frequency
- Quarterly
- Latest ex-date
- 1 Oct 2026
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.2150) ÷ latest price ($31.31) × 100 = 0.69%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (2 payments)
| Ex-date | Amount per unit |
|---|---|
| 1 Oct 2026 | $0.1300 |
| 1 Jul 2026 | $0.0850 |
Filings and sources
- Form N-PORT report for June 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000099627) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- TRUH and VTI Vanguard Morningstar Total Stock Market ETF
- TRUH and VOO Vanguard S&P 500 ETF
- TRUH and IVV iShares Core S&P 500 ETF
- TRUH and QQQ Invesco QQQ Trust, Series 1